High Throughput Formulation is to speed up formulation development by rapidly progressing the purified biotherapeutic protein/peptide into a Drug Product that can be evaluated in clinical studies. There ... number of…
With the advent of Biotechnology more and more human recombinant protein biotherapeutics have replaced the animal derived drug products. Th is has helped in global availability of quality drug products ... competitive…
Biotherapeutics and nutritional biotherapy have become important to reverse global chronic diseases such as non alcoholic fatty liver disease, diabetes and neurodegenerative diseases such as Alzheimer’s disease and…
Although paediatric biotherapeutic doses are frequently calculated using the patient's body weight (mg/kg) or body surface area (mg/m2), linear body size dosage adjustment is extremely empirical ... pharmacokinetic…
With these values it can be concluded that these phytochemicals can be used as biotherapeutics in regulating the notch thus making alterations in the Notch signaling system and achieving ... pathway will serve to be a…
poor selectivity, gradual replacement of current cancer drugs and other synthetic agents with appropriate biotherapeutic substances is proposed to overcome the challenges associated with the use of these synthetic…
Therapeutic proteins now represent a growing and critical component of drug development. Biotherapeutics such as antibodies, recombinant enzymes, gene and cell therapies continue to revolutionize the treatment of many…
market of bioactive functional ingredients and biotherapeutics has been increased to US $ 167 billion per year at a 7.3% increase in 2014 and is expected to US $ 279 billion ... demonstrate the suitability of those…
needed to prevent further recurrences. Microbiome research has led to the development of live biotherapeutic products (LBPs) to restore GI colonization resistance and break the cycle of rCDI. While derived
methods has enabled a better understanding of the structure and structure–function relationship of biotherapeutics. An important evolution of the regulatory landscape has been observed, but the recent development…
recently begun phase I clinical trials. Researchers looking into ferritin and other protein-based biotherapeutics can profit and be interested right away from this rich shortlist of recent advancements